Jump Financial, LLC Immuno Gen, Inc. Transaction History

Jump Financial, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$14.09 - $19.87 $2.03 Million - $2.87 Million	-144,290 Reduced 56.05%	113,128 $1.8 Million
Q3 2023 Nov 07, 2023	SELL	$14.09 - $19.87 $2.03 Million - $2.87 Million	-144,290 Reduced 56.05%	113,128 $1.8 Million
Q2 2023 Oct 21, 2024	BUY	$3.75 - $20.05 $883,691 - $4.72 Million	235,651 Added 1082.61%	257,418 $4.86 Million
Q2 2023 Aug 07, 2023	BUY	$3.75 - $20.05 $883,691 - $4.72 Million	235,651 Added 1082.61%	257,418 $4.86 Million
Q1 2023 Oct 21, 2024	BUY	$3.67 - $4.92 $79,884 - $107,093	21,767 New	21,767 $83,000
Q1 2023 May 03, 2023	BUY	$3.67 - $4.92 $29,187 - $39,128	7,953 Added 57.57%	21,767 $83,000
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $934,233 - $1.3 Million	-205,326 Reduced 93.7%	13,814 $68,000
Q3 2022 Nov 07, 2022	BUY	$4.48 - $6.47 $840,085 - $1.21 Million	187,519 Added 593.02%	219,140 $1.05 Million
Q2 2022 Aug 09, 2022	SELL	$3.15 - $5.76 $30,003 - $54,864	-9,525 Reduced 23.15%	31,621 $142,000
Q1 2022 May 12, 2022	SELL	$4.26 - $7.48 $142,088 - $249,487	-33,354 Reduced 44.77%	41,146 $196,000
Q4 2021 Feb 10, 2022	BUY	$4.75 - $7.5 $306,147 - $483,390	64,452 Added 641.44%	74,500 $553,000
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $50,440 - $66,216	10,048 New	10,048 $57,000
Q2 2021 Aug 13, 2021	SELL	$5.79 - $8.6 $242,543 - $360,254	-41,890 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $272,285 - $441,101	41,890 New	41,890 $339,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.